|
⚲
|
| Keyboard |
| Christopher Kroeger | |
|---|---|
| Firm | |
| Address | c/o Maplight Therapeutics, Inc 800 Chesapeake Drive Redwood City, CA 94063 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Maplight Therapeutics Inc | 021-552922 | Executive Officer | 188.2 M of 372.4 M |
||
| Maplight Therapeutics Inc | 021-487390 | Executive Officer | 105.0 M of 225.0 M |
||
| Maplight Therapeutics Inc | 021-464468 | Executive Officer | 12.0 M of 12.0 M |
||
| Maplight Therapeutics Inc | 021-391790 | Executive Officer | 30.0 M of 60.0 M |
||
| Maplight Therapeutics Inc | 021-347993 | Executive Officer | 16.0 M of 16.0 M |
||
| Cardiofocus Inc | 021-339933 | Director | 8.0 M of 12.0 M |
||
| Alvarado Therapeutics Inc | 021-334440 | Executive Officer | 5.0 M of 5.0 M |
||
| Cardiofocus Inc | 021-310429 | Director | 13.0 M of 21.0 M |
||
| Cardiofocus Inc | 021-281521 | Director | 20.2 M of 32.1 M |
||
| Cardiofocus Inc | 021-263388 | Director | 8.0 M of 12.0 M |
||
| Cardiofocus Inc | 021-231462 | Director | 31.7 M of 33.2 M |
||
| Cardiofocus Inc | 021-228262 | Director | 2.3 M of 2.3 M |
||
| Cardiofocus Inc | 021-217105 | Director | 2.4 M of 5.0 M |
||
| Cantex Pharmaceuticals Inc | 021-192030 | Director | 3.3 M of 3.3 M |
||
| Cardioxyl Pharmaceuticals Inc | 021-186614 | Executive Officer | 28.1 M of 28.1 M |
||
| Cardiofocus Inc | 021-155798 | Director | 13.6 M of 15.6 M |
||
| Paringenix Inc | 021-145926 | Director | 4.4 M of 5.0 M |
||
| Cardioxyl Pharmaceuticals Inc | 021-145689 | Executive Officer | 15.0 M of 15.0 M |
||
| Cardiofocus Inc | 021-140847 | Director | 5.0 M of 5.0 M |
||
| Cardioxyl Pharmaceuticals Inc | 021-96914 | Executive Officer | 9.0 M of 9.0 M |
||
| Cardiofocus Inc | 021-132258 | Director | 5.9 M of 9.2 M |
||